cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Adam Mudinillah
Contact Email
adammudinillah@staialhikmahpariangan.ac.id
Phone
+6285379388533
Journal Mail Official
adammudinillah@staialhikmahpariangan.ac.id
Editorial Address
Jorong Kubang Kaciak Dusun Kubang Kaciak, Kelurahan Balai Tangah, Kecamatan Lintau Buo Utara, Kabupaten Tanah Datar, Provinsi Sumatera Barat, Kodepos 27293.
Location
Kab. tanah datar,
Sumatera barat
INDONESIA
Journal of Biomedical and Techno Nanomaterials
Published by Yayasan Adra Karima Hubbi
ISSN : 30481120     EISSN : 30481155     DOI : 10.70177/jbtn
Core Subject : Science,
Biochemistry, Genetics & Molecular Biology
Journal of Biomedical and Techno Nanomaterials is an international forum for the publication of peer-reviewed integrative review articles, special thematic issues, reflections or comments on previous research or new research directions, interviews, replications, and intervention articles - all pertaining to the research fields of medicine, pharmaceuticals, biomaterials, biotechnology, diagnosis and prevention of diseases, biomedical devices, bioinformatics, and all other related fields of biomedical and life sciences. All publications provide breadth of coverage appropriate to a wide readership in Biomedical and Techno Nanomaterials research depth to inform specialists in that area. We feel that the rapidly growing Journal of Biomedical and Techno Nanomaterials community is looking for a journal with this profile that we can achieve together. Submitted papers must be written in English for initial review stage by editors and further review process by minimum two international reviewers.
Arjuna Subject : Biokimia, Genetika dan Biologi Molekuler - Biokimia, Genetika dan Biologi Molekuler (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Vol. 1 No. 1 (2024)" : 5 Documents clear
Negative Impact of Gene Therapy on Melanoma Disease Inzagi, Nadhea Aurel Zalfanisa; Samasta, Nadia Azhar; A’la, Dewi Ghitsatul; Sa’id, Ibrahim Bin
Journal of Biomedical and Techno Nanomaterials Vol. 1 No. 1 (2024)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The incidence of melanoma is rapidly increasing worldwide, posing a significant public health problem. Gene therapy for treating diseases has been discovered since 1989. Research developments to make gene therapy an effective treatment method are ongoing. Primary extracutaneous melanoma can be ocular, gastrointestinal, mucosal, leptomeningeal, genitourinary, and lymphatic. The relationship between ultraviolet (UV) exposure and the development of melanoma is highly acute and complex, and intermittent sun exposure significantly increases the risk of melanoma. It is the fifth most common type of cancer in men and the sixth in women. Mucosal melanoma is a rare disease that differs from melanoma arising elsewhere in the body. Although melanocytes are most abundant in the skin, they can also be found in smaller numbers in mucous membranes and the eyes. There are epidemiological, genetic, and physiological differences between melanomas arising from melanocytes in these various locations, and these differences have important implications for both disease prognosis and treatment.
Comparative Analysis of Biomaterials and Biodevices Utilized in Cardiac Surgery: A Multinational Study Goldstein, Grace; Rachel, Vaishnaw; Neeshi, Bulczynski
Journal of Biomedical and Techno Nanomaterials Vol. 1 No. 1 (2024)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Cardiac surgery is a critical field where the selection of biomaterials and biodevices can significantly impact patient outcomes. Different countries utilize various biomaterials and biodevices in cardiac procedures, influenced by factors such as technological advancement, regulatory environments, and healthcare infrastructure. Understanding the comparative effectiveness of these materials and devices across different regions is essential for optimizing patient care. This study aims to conduct a comparative analysis of biomaterials and biodevices used in cardiac surgery across multiple countries. The research seeks to evaluate the effectiveness, safety, and patient outcomes associated with these materials and devices, providing insights into best practices and potential areas for improvement. A mixed-methods approach was employed, combining quantitative data from clinical trials and patient records with qualitative insights from healthcare professionals. Data were collected from cardiac surgery centers in the United States, Germany, Japan, and Brazil. Quantitative measures included patient recovery rates, complication rates, and device longevity. Qualitative data were gathered through interviews and surveys with surgeons and medical staff, focusing on their experiences and perceptions of the materials and devices used. The study found significant variations in the effectiveness and safety of biomaterials and biodevices across different countries. Biomaterials used in Germany and Japan showed higher patient recovery rates and lower complication rates compared to those used in the United States and Brazil. Differences in regulatory standards, technological access, and surgeon preferences were identified as key factors influencing these outcomes. Qualitative data indicated a preference for locally produced devices in Japan and Germany, attributed to higher perceived quality and reliability. This multinational study highlights the disparities in the use and outcomes of biomaterials and biodevices in cardiac surgery. The findings suggest that adopting best practices and high-quality materials from countries with superior outcomes could enhance patient care globally. Further research and international collaboration are recommended to standardize the use of biomaterials and biodevices, ensuring optimal patient outcomes in cardiac surgery.
Innovations in Nanomedicine for Diabetes Management: Insights from Cross-Continental Research Joan, Hullavarad; Braley, Emily; Denise, Zheng
Journal of Biomedical and Techno Nanomaterials Vol. 1 No. 1 (2024)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Diabetes is a global health challenge affecting millions worldwide. Traditional diabetes management approaches, while effective, often face limitations in terms of precision, efficacy, and patient compliance. Recent advancements in nanomedicine offer promising solutions to these challenges by enabling targeted drug delivery, enhanced monitoring, and improved therapeutic outcomes. This study aims to explore the latest innovations in nanomedicine for diabetes management and evaluate their effectiveness through cross-continental research. The aim is to identify critical advancements, compare their efficacy across different populations, and provide insights into their potential global impact. A comprehensive literature review and meta-analysis covered research studies from North America, Europe, and Asia. Data were collected on various nanomedicine-based interventions, including nanoparticle drug delivery systems, nano biosensors, and nanotherapeutics. The effectiveness of these innovations was assessed based on parameters such as blood glucose control, complication reduction, patient adherence, and overall health outcomes. The analysis revealed that nanomedicine-based interventions significantly improve diabetes management across all studied populations. Nanoparticle drug delivery systems demonstrated enhanced bioavailability and sustained insulin release, improving blood glucose control. Nanobiosensors provided high accuracy in real-time monitoring of glucose levels, improving patient adherence to treatment regimens. Nanotherapeutics showed potential in reducing diabetes-related complications, such as neuropathy and retinopathy, through targeted action and minimal side effects. Innovations in nanomedicine present a transformative approach to diabetes management, offering improved efficacy, precision, and patient compliance. The cross-continental research highlights the universal benefits of these advancements despite regional differences in healthcare infrastructure and patient demographics. Further research and collaboration are recommended to optimize these technologies for broader clinical applications and address remaining implementation challenges.
Structural Variations in Nucleic Acids Across Different Populations: A Comparative Study Sahil, Ziming
Journal of Biomedical and Techno Nanomaterials Vol. 1 No. 1 (2024)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Structural variations in nucleic acids play a crucial role in genetic diversity and disease susceptibility among different populations. Understanding these variations provides valuable insights into human evolution, genetic predisposition to diseases, and responses to treatments. A comparative study of structural variations across populations is essential to identify population-specific genetic patterns. This study aims to analyze structural variations in nucleic acids across different populations, identify key differences among them, and understand the biological and medical implications of these variations. The ultimate goal is to provide comprehensive data that can be used for further research in population genetics and public health. The study employed a comparative approach using bioinformatics analysis of genomic data from various populations worldwide. Genomic data were obtained from public genomic databases and analyzed to identify structural variations, including deletions, duplications, inversions, and translocations. Next-Generation Sequencing (NGS) techniques were utilized to ensure high accuracy and resolution in identifying structural variations. The results revealed significant differences in structural variations among the populations studied. Certain structural variations were found to be more prevalent in specific populations, indicating natural selection and local adaptation. Additionally, variations associated with genetic diseases showed varying frequencies across populations. This study highlights the importance of structural variations in nucleic acids as a determinant of genetic diversity among different populations. The findings contribute valuable insights into human evolution and have significant implications for health, particularly in developing personalized medical strategies. Further research is needed to explore the impact of these structural variations on biological functions and human health.
Cross-Country Evaluation of Protein Engineering Techniques for Disease Treatment Eduardom, Charles; Amanda, Joo
Journal of Biomedical and Techno Nanomaterials Vol. 1 No. 1 (2024)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chronic and degenerative diseases have posed global challenges in the healthcare domain. Protein engineering techniques have emerged as a promising approach for developing effective protein-based therapies to address various diseases. However, the application of these techniques can vary across countries, depending on available resources, research infrastructure, and regulatory policies. This research aims to evaluate and compare the implementation of protein engineering techniques for disease treatment across different countries. Specifically, it analyzes the factors influencing the adoption of these techniques and identifies best practices and challenges faced in each country. This cross-country study involves data collection from various sources, including literature reviews, surveys, and interviews with experts in protein engineering and drug development. The data is analyzed both qualitatively and quantitatively to assess the level of adoption of protein engineering techniques, success in therapy development, and factors influencing progress in each country. The findings reveal that the adoption and success of protein engineering techniques for disease treatment vary across countries. Countries with adequate research resources, strong infrastructure, and supportive regulatory policies tend to have higher levels of adoption and success. In contrast, countries with limited resources and stringent regulations face challenges in effectively implementing these techniques. This research highlights the importance of international collaboration, technology transfer, and regulatory harmonization in promoting the global adoption of protein engineering techniques for disease treatment. By identifying best practices and addressing existing challenges, the potential of protein engineering techniques can be more widely leveraged to develop more effective and affordable therapies for patients worldwide.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2024 2024


Reset
Filter By Issues
All Issue Vol. 2 No. 6 (2025) Vol. 2 No. 5 (2025) Vol. 2 No. 4 (2025) Vol. 2 No. 3 (2025) Vol. 2 No. 2 (2025) Vol. 2 No. 1 (2025) Vol. 1 No. 4 (2024) Vol. 1 No. 3 (2024) Vol. 1 No. 2 (2024) Vol. 1 No. 1 (2024)